Novartis
Portland, Oregon 97228
http://www.pharma.us.novartis.com/index.jsp?usertrack.filter_applied=true&NovaId=2935376988539144257
Novartis, which was created in 1996 by the merger of the Swiss companies Ciba-Geigy and Sandoz, is a world leader providing healthcare solutions that address the evolving needs of patients and societies.
Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care, cost-saving generic pharmaceuticals, consumer health products, preventive vaccines. Novartis is the only company with leading positions in all these areas.
Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 127,000 full-time-equivalent associates globally.
We've found
17 trials
at this facility
Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Rheumatology Clinical Trial
Updated: 12/31/1969
Secukinumab Safety and Efficacy in JPsA and ERA
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
Updated: 12/31/1969
Efficacy, Safety and Tolerability of BAF312 Compared to Placebo in Patients With Intracerebral Hemorrhage (ICH).
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Scelrosis Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Asthma Clinical Trial
Updated: 12/31/1969
Study of Efficacy and Safety of QAW039 When Added to Standard-of-care Asthma Therapy in Patients With Uncontrolled Asthma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neoplasms, Breast Clinical Trial
Updated: 4/4/2016
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Status: Enrolling,
Phase
IV
Updated: 4/4/2016
Click here to add this to my saved trials
Cardiovascular Events Clinical Trial
Updated: 8/29/2013
A Randomized Controlled Trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly People
Status: Enrolling,
Phase
III
Updated: 8/29/2013
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDS
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 12/31/1969
Study of Efficacy and Safety of Secukinumab 2 mL Auto-injector (300 mg) in Subjects With Moderate to Severe Plaque Psoriasis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Updated: 1/15/2015
Study to Evaluate the Long Term Efficacy, Safety and Tolerability of Secukinumab in Patients With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 1/15/2015
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 12/31/1969
Study to Explore the Effect of Secukinumab, Compared to Placebo, on Fat Tissue and Skin in Plaque Psoriasis Patients
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic and Advanced Solid Tumors Clinical Trial
Updated: 12/31/1969
A Phase I/Ib Study of NIZ985 in Combination With PDR001 in Adults With Metastatic Cancers
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Asthma Clinical Trial
Updated: 12/31/1969
A Multicenter Randomized 52 Week Treatment Double-blind, Triple Dummy Parallel Group Study to Assess the Efficacy and Safety of QMF149 Compared to Mometasone Furoate in Patients With Asthma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ankylosing Spondylitis Clinical Trial
Updated: 12/31/1969
Study Estimating the Clinical Difference Between 300 mg and 150 mg of Secukinumab Following Dose Escalation to 300 mg in Patients With Ankylosing Spondylitis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Systemic Juvenile Idiopathic Arthritis Clinical Trial
Updated: 3/6/2014
An Open-label, Multi-arm, Non-comparative Safety and Tolerability Study of Canakinumab (ACZ885) in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)
Status: Upcoming,
Phase
III
Updated: 3/6/2014
Click here to add this to my saved trials